Overview of SARS-COV-2 infection at the Butantan Penitentiary Progression Center

被引:1
作者
Andrade, Soraya Gomes de Amorim [1 ]
Andrade, Fernando Moreira [1 ]
da Silva, Anderson [2 ]
Cardoso, Maria Regina Alves [3 ]
Ferraz, Guilherme Rodrigues [2 ]
de Barros, Eliana Nogueira Castro [2 ]
Braga, Patricia Emilia [2 ]
Cristofalo, Milena Martello [1 ,4 ,6 ]
Vieira, Julia Rabello Guerra [4 ]
Lopes, Carolina de Souza [5 ]
Niyama, Alyne [4 ]
de Carvalho, Juliana Lima [4 ]
Aldrighi, Jose Mendes [1 ]
机构
[1] Univ Sao Paulo, Fac Saude Publ, Dept Saude Ciclos Vida & Soc, Sao Paulo, SP, Brazil
[2] Inst Butantan, Sao Paulo, SP, Brazil
[3] Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, Sao Paulo, SP, Brazil
[4] Santa Casa Sao Paulo, Fac Ciencias Med, Sao Paulo, SP, Brazil
[5] Ctr Univ Sao Camilo, Fac Med, Sao Paulo, SP, Brazil
[6] Univ Sao Paulo, Fac Saude Publ, Ave Doutor Arnaldo 715, BR-01246904 Sao Paulo, SP, Brazil
来源
REVISTA DE SAUDE PUBLICA | 2023年 / 57卷
关键词
Prisoners; SARS-CoV-2; COVID-19; Testing; Risk Factors; Prevalence; Prisons; CORONAVIRUS DISEASE 2019; COVID-19; PRISON; HEALTH; CITY;
D O I
10.11606/s1518-8787.2023057004717
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
OBJECTIVE: To estimate the prevalence of exposure to the SARS-CoV-2 virus among individuals living in restricted freedom.METHODS: A seroprevalence survey was carried out with the population of the female penitentiary of the Centro de Progressao Penitenciaria (CPP) in Butantan (municipality of Sao Paulo), between June 24 and August 20, 2020. During this period, according to the Secretariat of Penitentiary Administration (SAP), the positivity of rapid tests among inmates ranged from 65% to 78%. The evaluation method used in the study was the "One Step COVID-19" rapid test (chromatography), from the company Wondfo, also using the RT-PCR method in symptomatic participants to confirm the viral condition. The study population consisted of 879 female inmates and 170 employees of the institution.RESULTS: The prevalence of total antibodies (IgG/IgM) against the SARS-CoV-2 virus in the total population of 1049 study participants was 6.1%; among the population of 879 inmates, a prevalence of 5.8% was observed, and among the institution's employees, 7.5%.CONCLUSIONS: The prevalence of covid-19 at the Butantan CPP was low, which is due to the implementation of simple prevention measures at the institution, such as the use of mask s (with appropriate changes), emphasis on hygiene, hand washing and social distancing, in addition to other strategies, such as suspending inmates' visits from relatives and friends and cutting back on elective medical appointments and outside work.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Exosomes and SARS-CoV-2 infection
    Li, Liuying
    Yang, Zixuan
    Li, Jia
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [42] SARS-CoV-2 Infection in Pregnant Women With Hypothyroidism
    Iordache, Madalina Daniela
    Meca, Daniela Catalina
    Cirstoiu, Monica Mihaela
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [43] Olfactory and gustatory dysfunctions in SARS-CoV-2 infection: A systematic review
    Boscutti, A.
    Delvecchio, G.
    Pigoni, A.
    Cereda, G.
    Ciappolino, V.
    Bellani, M.
    Fusar-Poli, P.
    Brambilla, P.
    BRAIN BEHAVIOR & IMMUNITY-HEALTH, 2021, 15
  • [44] SARS-COV-2 infection and lung tumor microenvironment
    Naila Malkani
    Muhammad Usman Rashid
    Molecular Biology Reports, 2021, 48 : 1925 - 1934
  • [45] Age-Dependent Progression of SARS-CoV-2 Infection in Syrian Hamsters
    Osterrieder, Nikolaus
    Bertzbach, Luca D.
    Dietert, Kristina
    Abdelgawad, Azza
    Vladimirova, Daria
    Kunec, Dusan
    Hoffmann, Donata
    Beer, Martin
    Gruber, Achim D.
    Trimpert, Jakob
    VIRUSES-BASEL, 2020, 12 (07):
  • [46] Innate Immune Response in SARS-CoV-2 Infection
    Schiuma, Giovanna
    Beltrami, Silvia
    Bortolotti, Daria
    Rizzo, Sabrina
    Rizzo, Roberta
    MICROORGANISMS, 2022, 10 (03)
  • [47] The Pathogenicity of MERS-CoV, SARS-CoV and SARS-CoV-2: A Comparative Overview
    Shashank, Patil M.
    Prithvi, Shirahatti S.
    Ramith, Ramu
    RESEARCH JOURNAL OF BIOTECHNOLOGY, 2021, 16 (01): : 182 - 192
  • [48] Human Cell Organelles in SARS-CoV-2 Infection: An Up-to-Date Overview
    Goracy, Anna
    Rosik, Jakub
    Szostak, Bartosz
    Ustianowski, Lukasz
    Ustianowska, Klaudia
    Goracy, Jaroslaw
    VIRUSES-BASEL, 2022, 14 (05):
  • [49] Evaluation of SARS-CoV-2 diagnostics and risk factors associated with SARS-CoV-2 infection in Zambia
    Tembo, John
    Egbe, Nkongho Franklyn
    Maluzi, Kwitaka
    Mulonga, Kangwa
    Chilufya, Moses
    Kapata, Nathan
    Mukonka, Victor
    Simulundu, Edgar
    Zumla, Alimuddin
    Fwoloshi, Sombo
    Mulenga, Lloyd
    Pallerla, Srinivas Reddy
    Velavan, Thirumalaisamy P.
    Bates, Matthew
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 120 : 150 - 157
  • [50] Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past
    Shah, Vibhuti Kumar
    Firmal, Priyanka
    Alam, Aftab
    Ganguly, Dipyaman
    Chattopadhyay, Samit
    FRONTIERS IN IMMUNOLOGY, 2020, 11